$FNF
Fidelity National Financial, Inc.

2024 Q2 Form 10-Q Financial Statement

#000133187524000029 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $3.158B $3.299B
YoY Change 2.93% 33.35%
Cost Of Revenue $61.00M
YoY Change 8.93%
Gross Profit $3.097B
YoY Change 2.82%
Gross Profit Margin 98.07%
Selling, General & Admin $779.0M $727.0M
YoY Change 3.18% 7.39%
% of Gross Profit 25.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$182.0M $167.0M
YoY Change 56.9% 24.63%
% of Gross Profit -5.88%
Operating Expenses $2.684B $2.919B
YoY Change -1.07% 16.29%
Operating Profit $413.0M
YoY Change 38.13%
Interest Expense $47.00M $49.00M
YoY Change 9.3% 16.67%
% of Operating Profit 11.38%
Other Income/Expense, Net
YoY Change
Pretax Income $458.0M $331.0M
YoY Change 37.95% -547.3%
Income Tax $116.0M $63.00M
% Of Pretax Income 25.33% 19.03%
Net Earnings $306.0M $248.0M
YoY Change 39.73% -520.34%
Net Earnings / Revenue 9.69% 7.52%
Basic Earnings Per Share $0.92
Diluted Earnings Per Share $1.12 $0.91
COMMON SHARES
Basic Shares Outstanding 273.2M shares 273.2M shares
Diluted Shares Outstanding 273.0M shares 272.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.890B $3.517B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $170.0M $167.0M
YoY Change -2.86% -5.65%
Goodwill $5.107B $5.107B
YoY Change 6.15% 6.6%
Intangibles
YoY Change
Long-Term Investments $3.931B $3.632B
YoY Change 29.35% 25.72%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $88.82B $84.50B
YoY Change 21.64% 21.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $386.0M $390.0M
YoY Change -6.08% -4.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.560B $4.235B
YoY Change 13.29% 19.16%
LONG-TERM LIABILITIES
Long-Term Debt $4.175B $3.884B
YoY Change 12.96% 5.09%
Other Long-Term Liabilities $459.0M $425.0M
YoY Change 46.65%
Total Long-Term Liabilities $4.634B $4.309B
YoY Change 25.38% 16.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.560B $4.235B
Total Long-Term Liabilities $4.634B $4.309B
Total Liabilities $80.84B $76.66B
YoY Change 21.85% 21.67%
SHAREHOLDERS EQUITY
Retained Earnings $5.536B $5.361B
YoY Change 7.7% 6.28%
Common Stock $5.942B $5.924B
YoY Change 1.0% 0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.131B $2.131B
YoY Change 0.85% 0.85%
Treasury Stock Shares
Shareholders Equity $7.260B $7.125B
YoY Change
Total Liabilities & Shareholders Equity $88.82B $84.50B
YoY Change 21.64% 21.31%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $306.0M $248.0M
YoY Change 39.73% -520.34%
Depreciation, Depletion And Amortization -$182.0M $167.0M
YoY Change 56.9% 24.63%
Cash From Operating Activities $1.363B $1.591B
YoY Change -20.8% 12.2%
INVESTING ACTIVITIES
Capital Expenditures $41.00M $35.00M
YoY Change 17.14% 2.94%
Acquisitions
YoY Change
Other Investing Activities -$1.884B -$1.061B
YoY Change -1.41%
Cash From Investing Activities -$1.925B -$1.096B
YoY Change -1.08% -52.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.935B $255.0M
YoY Change 258.33% -81.81%
NET CHANGE
Cash From Operating Activities 1.363B $1.591B
Cash From Investing Activities -1.925B -$1.096B
Cash From Financing Activities 1.935B $255.0M
Net Change In Cash 1.373B $750.0M
YoY Change 335.87% 40.19%
FREE CASH FLOW
Cash From Operating Activities $1.363B $1.591B
Capital Expenditures $41.00M $35.00M
Free Cash Flow $1.322B $1.556B
YoY Change -21.59% 12.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2024Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2023Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2023Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2023Q4 fnf Intangible Assets Net Excluding Goodwilland Title Plants
IntangibleAssetsNetExcludingGoodwillandTitlePlants
4627000000 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329206677 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329185916 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5924000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5913000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5361000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5244000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2029000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2119000000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
55968232 shares
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29000000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
55934467 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2131000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2130000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
7125000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6908000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
712000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
552000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7837000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7460000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84496000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80614000000 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
710000000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
611000000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
275000000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
5000000 usd
CY2024Q1 us-gaap Revenues
Revenues
3299000000 usd
CY2023Q1 us-gaap Revenues
Revenues
2474000000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
727000000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
677000000 usd
CY2024Q1 us-gaap Insurance Commissions
InsuranceCommissions
460000000 usd
CY2023Q1 us-gaap Insurance Commissions
InsuranceCommissions
420000000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
369000000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
360000000 usd
CY2024Q1 fnf Policyholder Benefits And Claims Incurred Net Life And Annuity Remeasurement Gains Losses
PolicyholderBenefitsAndClaimsIncurredNetLifeAndAnnuityRemeasurementGainsLosses
1161000000 usd
CY2023Q1 fnf Policyholder Benefits And Claims Incurred Net Life And Annuity Remeasurement Gains Losses
PolicyholderBenefitsAndClaimsIncurredNetLifeAndAnnuityRemeasurementGainsLosses
812000000 usd
CY2024Q1 us-gaap Market Risk Benefit Change In Fair Value Gain Loss
MarketRiskBenefitChangeInFairValueGainLoss
11000000 usd
CY2023Q1 us-gaap Market Risk Benefit Change In Fair Value Gain Loss
MarketRiskBenefitChangeInFairValueGainLoss
-59000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
167000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
134000000 usd
CY2024Q1 us-gaap Policyholder Benefits And Claims Incurred Other
PolicyholderBenefitsAndClaimsIncurredOther
46000000 usd
CY2023Q1 us-gaap Policyholder Benefits And Claims Incurred Other
PolicyholderBenefitsAndClaimsIncurredOther
44000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
49000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
42000000 usd
CY2024Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
2968000000 usd
CY2023Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
2548000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
331000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-74000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2024Q1 fnf Income Loss From Continuing Operations Before Minority Interest And Income Loss On Equity Method Investments Net Of Income Tax
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossOnEquityMethodInvestmentsNetOfIncomeTax
268000000 usd
CY2023Q1 fnf Income Loss From Continuing Operations Before Minority Interest And Income Loss On Equity Method Investments Net Of Income Tax
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossOnEquityMethodInvestmentsNetOfIncomeTax
-88000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
269000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-88000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
248000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-59000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.92
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.91
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
271000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
270000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
272000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
271000000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
269000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-88000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
349000000 usd
CY2024Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
13000000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
11000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-13000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-35000000 usd
CY2024Q1 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
91000000 usd
CY2023Q1 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
-100000000 usd
CY2024Q1 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax
1000000 usd
CY2023Q1 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax
7000000 usd
CY2024Q1 fnf Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest Spinoff
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterestSpinoff
17000000 usd
CY2023Q1 fnf Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest Spinoff
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterestSpinoff
43000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
90000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
260000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
359000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
172000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
21000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-29000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
338000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
201000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
88000000 usd
CY2024Q1 us-gaap Oci Equity Method Investment Tax
OciEquityMethodInvestmentTax
4000000 usd
CY2023Q1 us-gaap Oci Equity Method Investment Tax
OciEquityMethodInvestmentTax
3000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-4000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-9000000 usd
CY2024Q1 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax
24000000 usd
CY2023Q1 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax
-27000000 usd
CY2024Q1 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Tax
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax
1000000 usd
CY2023Q1 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Tax
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax
2000000 usd
CY2024Q1 fnf Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest Spinoff
OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterestSpinoff
-5000000 usd
CY2023Q1 fnf Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest Spinoff
OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterestSpinoff
-11000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6569000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
20000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
349000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-35000000 usd
CY2023Q1 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax
7000000 usd
CY2023Q1 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
-100000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
13000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
122000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-88000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6648000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7460000000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
136000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
7000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5000000 usd
CY2024Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
13000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-13000000 usd
CY2024Q1 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
91000000 usd
CY2024Q1 us-gaap Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax
OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax
1000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
16000000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
131000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
7000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
269000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7837000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
269000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-88000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
167000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
134000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2024Q1 fnf Gain Loss On Investments And Disposition Of Other Assets
GainLossOnInvestmentsAndDispositionOfOtherAssets
25000000 usd
CY2023Q1 fnf Gain Loss On Investments And Disposition Of Other Assets
GainLossOnInvestmentsAndDispositionOfOtherAssets
-213000000 usd
CY2024Q1 fnf Increase Decrease Interest Credited To Policy Owner Account
IncreaseDecreaseInterestCreditedToPolicyOwnerAccount
513000000 usd
CY2023Q1 fnf Increase Decrease Interest Credited To Policy Owner Account
IncreaseDecreaseInterestCreditedToPolicyOwnerAccount
542000000 usd
CY2024Q1 fnf Market Risk Benefit Increase Decrease Net
MarketRiskBenefitIncreaseDecreaseNet
-11000000 usd
CY2023Q1 fnf Market Risk Benefit Increase Decrease Net
MarketRiskBenefitIncreaseDecreaseNet
60000000 usd
CY2024Q1 fnf Increase Decrease In Deferred Policy Acquisition Costs And Deferred Sales Inducements
IncreaseDecreaseInDeferredPolicyAcquisitionCostsAndDeferredSalesInducements
311000000 usd
CY2023Q1 fnf Increase Decrease In Deferred Policy Acquisition Costs And Deferred Sales Inducements
IncreaseDecreaseInDeferredPolicyAcquisitionCostsAndDeferredSalesInducements
251000000 usd
CY2024Q1 fnf Charges Assessed To Contract Holders For Mortality And Administration
ChargesAssessedToContractHoldersForMortalityAndAdministration
66000000 usd
CY2023Q1 fnf Charges Assessed To Contract Holders For Mortality And Administration
ChargesAssessedToContractHoldersForMortalityAndAdministration
58000000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
33000000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
35000000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
38000000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
39000000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
19000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
36000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14000000 usd
CY2024Q1 fnf Unrealized Gain Loss In Net Asset Value Of Limited Partnerships
UnrealizedGainLossInNetAssetValueOfLimitedPartnerships
49000000 usd
CY2023Q1 fnf Unrealized Gain Loss In Net Asset Value Of Limited Partnerships
UnrealizedGainLossInNetAssetValueOfLimitedPartnerships
57000000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
254000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
216000000 usd
CY2024Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
22000000 usd
CY2023Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
79000000 usd
CY2024Q1 us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
505000000 usd
CY2023Q1 us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
224000000 usd
CY2024Q1 us-gaap Increase Decrease In Reinsurance Payables
IncreaseDecreaseInReinsurancePayables
940000000 usd
CY2023Q1 us-gaap Increase Decrease In Reinsurance Payables
IncreaseDecreaseInReinsurancePayables
1124000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45000000 usd
CY2024Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-24000000 usd
CY2023Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-19000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
33000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-28000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
111000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
174000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1591000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1418000000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1783000000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1091000000 usd
CY2024Q1 fnf Payments To Acquire Property Plant And Equipment Software And Title Plants
PaymentsToAcquirePropertyPlantAndEquipmentSoftwareAndTitlePlants
35000000 usd
CY2023Q1 fnf Payments To Acquire Property Plant And Equipment Software And Title Plants
PaymentsToAcquirePropertyPlantAndEquipmentSoftwareAndTitlePlants
34000000 usd
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3819000000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4077000000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1473000000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1249000000 usd
CY2024Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
3000000 usd
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
4000000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
25000000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0 usd
CY2024Q1 fnf Payments To Acquire Businesses Net Of Dispositions
PaymentsToAcquireBusinessesNetOfDispositions
284000000 usd
CY2023Q1 fnf Payments To Acquire Businesses Net Of Dispositions
PaymentsToAcquireBusinessesNetOfDispositions
273000000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
272000000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
327000000 usd
CY2024Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
36000000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
90000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1096000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2285000000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
7000000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
500000000 usd
CY2024Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
5000000 usd
CY2023Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
10000000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-35000000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
130000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
122000000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
7000000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
7000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
7000000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
20000000 usd
CY2024Q1 fnf Payments For Proceeds From Secured Trust Deposits
PaymentsForProceedsFromSecuredTrustDeposits
38000000 usd
CY2023Q1 fnf Payments For Proceeds From Secured Trust Deposits
PaymentsForProceedsFromSecuredTrustDeposits
61000000 usd
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5000000 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2000000 usd
CY2024Q1 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
1929000000 usd
CY2023Q1 us-gaap Proceeds From Annuities And Investment Certificates
ProceedsFromAnnuitiesAndInvestmentCertificates
2115000000 usd
CY2024Q1 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
1483000000 usd
CY2023Q1 us-gaap Repayments Of Annuities And Investment Certificates
RepaymentsOfAnnuitiesAndInvestmentCertificates
950000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
255000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1402000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
750000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
535000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2767000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2286000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3517000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2821000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2024Q1 fnf Income Tax Expense As Percentage Of Earnings Before Income Taxes Percent
IncomeTaxExpenseAsPercentageOfEarningsBeforeIncomeTaxesPercent
0.19
CY2023Q1 fnf Income Tax Expense As Percentage Of Earnings Before Income Taxes Percent
IncomeTaxExpenseAsPercentageOfEarningsBeforeIncomeTaxesPercent
-0.19
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
21935000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
21246000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
47789000000 usd
CY2024Q1 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reserve for title claim losses follows:</span><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in insurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claim loss provision related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total title claim loss provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid, net of recoupments related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total title claims paid, net of recoupments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance of claim loss reserve for title insurance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for title insurance claim losses as a percentage of title insurance premiums</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1338000000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
5161000000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1312000000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4661000000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
228000000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
0 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
336000000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
0 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-67000000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
385000000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
0 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
96000000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
0 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-27000000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
CY2023Q4 fnf Assets Carried On Balance Sheet At Other Than Fair Value Amount
AssetsCarriedOnBalanceSheetAtOtherThanFairValueAmount
usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
47789000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
40000000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
500000000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3683000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
44566000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
45606000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
42000000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
457000000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3648000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
42373000000 usd
CY2024Q1 fnf Investment Non Income Producing Greater Than Twelve Months Fair Value Disclosure
InvestmentNonIncomeProducingGreaterThanTwelveMonthsFairValueDisclosure
69000000 usd
CY2023Q4 fnf Investment Non Income Producing Greater Than Twelve Months Fair Value Disclosure
InvestmentNonIncomeProducingGreaterThanTwelveMonthsFairValueDisclosure
47000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
516000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
481000000 usd
CY2024Q1 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
4518000000 usd
CY2023Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
4345000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
22844000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
22397000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
44566000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
45606000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
42373000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
40000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
42000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
6970000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
251000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
20098000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3386000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
27068000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3637000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
1371 security
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
2775 security
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
4146 security
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5841000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
302000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
20908000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3291000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
26749000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3593000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
1035 security
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
2846 security
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
3881 security
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
40000000 usd
CY2024Q1 fnf Debt Securities Available For Sale Unrealized Loss Position Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2023Q4 fnf Commercial Mortgage Loans Percentage Of Investments
CommercialMortgageLoansPercentageOfInvestments
0.05
CY2024Q1 fnf Commercial Mortgage Loans Percentage Of Investments
CommercialMortgageLoansPercentageOfInvestments
0.05
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff
0 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
0 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff
0 usd
CY2024Q1 fnf Debt Service Coverage Ratio Amortization Period
DebtServiceCoverageRatioAmortizationPeriod
P25Y
CY2024Q1 fnf Number Of Mortgage Loans Delinquent In Principal Or Interest
NumberOfMortgageLoansDelinquentInPrincipalOrInterest
0 loan
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
66000000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
57000000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
66000000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
57000000 usd
CY2024Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
58000000 usd
CY2023Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
41000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
66000000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1000000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
67000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
42000000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
18000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
60000000 usd
CY2024Q1 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
780000000 usd
CY2023Q1 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
673000000 usd
CY2024Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
70000000 usd
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
62000000 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
710000000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
611000000 usd
CY2024Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-19000000 usd
CY2023Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-50000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
60000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
-5000000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
0 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-4000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
21000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-89000000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
156000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
147000000 usd
CY2024Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
5000000 usd
CY2023Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
2000000 usd
CY2024Q1 fnf Change In Fair Value Derivatives Including Other Derivatives
ChangeInFairValueDerivativesIncludingOtherDerivatives
164000000 usd
CY2023Q1 fnf Change In Fair Value Derivatives Including Other Derivatives
ChangeInFairValueDerivativesIncludingOtherDerivatives
41000000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
275000000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
5000000 usd
CY2024Q1 fnf Reinsurance Agreement Recognized Gains Losses
ReinsuranceAgreementRecognizedGainsLosses
-19000000 usd
CY2023Q1 fnf Reinsurance Agreement Recognized Gains Losses
ReinsuranceAgreementRecognizedGainsLosses
-22000000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
583000000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
489000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
6000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
1000000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
25000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
51000000 usd
CY2024Q1 fnf Investments Owned Vie Unconsolidated Carrying Value
InvestmentsOwnedVIEUnconsolidatedCarryingValue
25358000000 usd
CY2024Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
29175000000 usd
CY2023Q4 fnf Investments Owned Vie Unconsolidated Carrying Value
InvestmentsOwnedVIEUnconsolidatedCarryingValue
23908000000 usd
CY2023Q4 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
27152000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
49000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
331000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000000 usd
CY2024Q1 fnf Income Loss From Continuing Operations Before Minority Interest And Income Loss On Equity Method Investments Net Of Income Tax
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossOnEquityMethodInvestmentsNetOfIncomeTax
268000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1188000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
977000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4698000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4258000000 usd
CY2024Q1 us-gaap Litigation Reserve
LitigationReserve
10000000 usd
CY2024Q1 us-gaap Premiums Written Net
PremiumsWrittenNet
1033000000 usd
CY2024Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
1281000000 usd
CY2024Q1 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
2314000000 usd
CY2024Q1 fnf Net Investment Income And Gain Loss On Investments
NetInvestmentIncomeAndGainLossOnInvestments
985000000 usd
CY2024Q1 us-gaap Revenues
Revenues
3299000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
167000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
269000000 usd
CY2024Q1 us-gaap Assets
Assets
84496000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5107000000 usd
CY2023Q1 us-gaap Premiums Written Net
PremiumsWrittenNet
978000000 usd
CY2023Q1 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
880000000 usd
CY2023Q1 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
1858000000 usd
CY2023Q1 fnf Net Investment Income And Gain Loss On Investments
NetInvestmentIncomeAndGainLossOnInvestments
616000000 usd
CY2023Q1 us-gaap Revenues
Revenues
2474000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
134000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
42000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-74000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2023Q1 fnf Income Loss From Continuing Operations Before Minority Interest And Income Loss On Equity Method Investments Net Of Income Tax
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossOnEquityMethodInvestmentsNetOfIncomeTax
-88000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-88000000 usd
CY2023Q1 us-gaap Assets
Assets
69654000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4791000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
57000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
34000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000000 usd
CY2024Q1 fnf Deferred Sales Inducements Paid
DeferredSalesInducementsPaid
54000000 usd
CY2023Q1 fnf Deferred Sales Inducements Paid
DeferredSalesInducementsPaid
29000000 usd
CY2024Q1 fnf Noncash Investingand Financing Activities Changein Proceedsof Salesof Investments
NoncashInvestingandFinancingActivitiesChangeinProceedsofSalesofInvestments
37000000 usd
CY2023Q1 fnf Noncash Investingand Financing Activities Changein Proceedsof Salesof Investments
NoncashInvestingandFinancingActivitiesChangeinProceedsofSalesofInvestments
-41000000 usd
CY2024Q1 fnf Noncash Investingand Financing Activities Changein Purchasesof Investments
NoncashInvestingandFinancingActivitiesChangeinPurchasesofInvestments
173000000 usd
CY2023Q1 fnf Noncash Investingand Financing Activities Changein Purchasesof Investments
NoncashInvestingandFinancingActivitiesChangeinPurchasesofInvestments
78000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9000000 usd
CY2024Q1 fnf Lessee Operating Lease Remeasurement Of Lease Liability
LesseeOperatingLeaseRemeasurementOfLeaseLiability
13000000 usd
CY2023Q1 fnf Lessee Operating Lease Remeasurement Of Lease Liability
LesseeOperatingLeaseRemeasurementOfLeaseLiability
19000000 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
474000000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
276000000 usd
CY2024Q1 fnf Non Cash Acquisition Assets Acquired Liabilities Assumed Consideration Before Liabilities And Noncontrolling Interest
NonCashAcquisitionAssetsAcquiredLiabilitiesAssumedConsiderationBeforeLiabilitiesAndNoncontrollingInterest
284000000 usd
CY2023Q1 fnf Non Cash Acquisition Assets Acquired Liabilities Assumed Consideration Before Liabilities And Noncontrolling Interest
NonCashAcquisitionAssetsAcquiredLiabilitiesAssumedConsiderationBeforeLiabilitiesAndNoncontrollingInterest
273000000 usd
CY2024Q1 fnf Noncash Or Part Noncash Acquisition Liabilities Assumed And Noncontrolling Interest
NoncashOrPartNoncashAcquisitionLiabilitiesAssumedAndNoncontrollingInterest
190000000 usd
CY2023Q1 fnf Noncash Or Part Noncash Acquisition Liabilities Assumed And Noncontrolling Interest
NoncashOrPartNoncashAcquisitionLiabilitiesAssumedAndNoncontrollingInterest
3000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
421000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
418000000 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
710000000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
611000000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
275000000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
5000000 usd
CY2024Q1 us-gaap Revenues
Revenues
3299000000 usd
CY2023Q1 us-gaap Revenues
Revenues
2474000000 usd
CY2024Q1 fnf Home Warranty Contract Period
HomeWarrantyContractPeriod
P1Y
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
310000000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
317000000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
90000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
91000000 usd
CY2024Q1 fnf Contract With Customer Policy Period
ContractWithCustomerPolicyPeriod
P1Y
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
34000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
32000000 usd
CY2024Q1 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1407000000 usd
CY2023Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1446000000 usd
CY2024Q1 fnf Deferred Policy Acquisition Costs Including Funding Agreements
DeferredPolicyAcquisitionCostsIncludingFundingAgreements
2412000000 usd
CY2023Q4 fnf Deferred Policy Acquisition Costs Including Funding Agreements
DeferredPolicyAcquisitionCostsIncludingFundingAgreements
2215000000 usd
CY2024Q1 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
392000000 usd
CY2023Q4 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
346000000 usd
CY2024Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5027000000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
4627000000 usd
CY2023Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1446000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
39000000 usd
CY2024Q1 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1407000000 usd
CY2022Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1615000000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
43000000 usd
CY2023Q1 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1572000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
39000000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
43000000 usd
CY2023Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
2211000000 usd
CY2024Q1 us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
257000000 usd
CY2024Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
60000000 usd
CY2024Q1 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
2408000000 usd
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1402000000 usd
CY2023Q1 us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
221000000 usd
CY2023Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
35000000 usd
CY2023Q1 fnf Deferred Policy Acquisition Cost Reinsurance Related Adjustments
DeferredPolicyAcquisitionCostReinsuranceRelatedAdjustments
79000000 usd
CY2023Q1 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1667000000 usd
CY2024Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
60000000 usd
CY2023Q1 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
35000000 usd
CY2024Q1 fnf Deferred Policy Acquisition Costs Including Funding Agreements
DeferredPolicyAcquisitionCostsIncludingFundingAgreements
2412000000 usd
CY2023Q4 fnf Deferred Policy Acquisition Costs Including Funding Agreements
DeferredPolicyAcquisitionCostsIncludingFundingAgreements
2215000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Remainder Of Fiscal Year
PresentValueOfFutureInsuranceProfitsAmortizationExpenseRemainderOfFiscalYear
111000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year One
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne
138000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Two
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo
126000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Three
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree
115000000 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Four
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFour
105000000 usd
CY2024Q1 fnf Present Value Of Future Insurance Profits Expected Amortization After Year Four
PresentValueOfFutureInsuranceProfitsExpectedAmortizationAfterYearFour
812000000 usd
CY2024Q1 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
1407000000 usd
CY2024Q1 fnf Reinsurance Retrocession Quota Share Basis Percentage
ReinsuranceRetrocessionQuotaShareBasisPercentage
0.90
CY2023 fnf Reinsurance Retrocession Quota Share Basis Percentage
ReinsuranceRetrocessionQuotaShareBasisPercentage
0.90
CY2023Q1 fnf Reinsurance Risk Charge Fee
ReinsuranceRiskChargeFee
10000000 usd
CY2024Q1 fnf Reinsurance Risk Charge Fee
ReinsuranceRiskChargeFee
10000000 usd
CY2023Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
21000000 usd
CY2022Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
10000000 usd
CY2024Q1 us-gaap Reinsurance Recoverable Change In Method Credit Loss Expense Reversal
ReinsuranceRecoverableChangeInMethodCreditLossExpenseReversal
0 usd
CY2023Q1 us-gaap Reinsurance Recoverable Change In Method Credit Loss Expense Reversal
ReinsuranceRecoverableChangeInMethodCreditLossExpenseReversal
1000000 usd
CY2024Q1 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
21000000 usd
CY2023Q1 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
9000000 usd
CY2024Q1 us-gaap Market Risk Benefit Asset Amount
MarketRiskBenefitAssetAmount
95000000 usd
CY2024Q1 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
425000000 usd
CY2024Q1 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
330000000 usd
CY2023Q4 us-gaap Market Risk Benefit Asset Amount
MarketRiskBenefitAssetAmount
88000000 usd
CY2023Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
403000000 usd
CY2023Q4 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
315000000 usd
CY2024Q1 fnf Policy Holder Account Balance Gross Liability
PolicyHolderAccountBalanceGrossLiability
50875000000 usd
CY2023Q4 fnf Policy Holder Account Balance Gross Liability
PolicyHolderAccountBalanceGrossLiability
48798000000 usd
CY2024Q1 fnf Policyholder Benefits And Claims Incurred Net Life And Annuity Change In Policy Reserves Increase Decrease
PolicyholderBenefitsAndClaimsIncurredNetLifeAndAnnuityChangeInPolicyReservesIncreaseDecrease
57000000 usd
CY2024Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
7441000000 usd
CY2023Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
7050000000 usd
CY2023Q1 fnf Liability For Future Policy Benefit Expected Future Policy Benefit Discounted Before Reinsurance
LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitDiscountedBeforeReinsurance
2155000000 usd
CY2023Q1 us-gaap Liability For Future Policy Benefit Expected Future Gross Premium Discounted Before Reinsurance
LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance
839000000 usd
CY2024Q1 us-gaap Liability For Future Policy Benefit Gross Premium Income
LiabilityForFuturePolicyBenefitGrossPremiumIncome
620000000 usd
CY2023Q1 us-gaap Liability For Future Policy Benefit Gross Premium Income
LiabilityForFuturePolicyBenefitGrossPremiumIncome
301000000 usd
CY2024Q1 us-gaap Liability For Future Policy Benefit Interest Expense
LiabilityForFuturePolicyBenefitInterestExpense
73000000 usd
CY2023Q1 us-gaap Liability For Future Policy Benefit Interest Expense
LiabilityForFuturePolicyBenefitInterestExpense
48000000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001331875-24-000029-index-headers.html Edgar Link pending
0001331875-24-000029-index.html Edgar Link pending
0001331875-24-000029.txt Edgar Link pending
0001331875-24-000029-xbrl.zip Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fnf-20240331.htm Edgar Link pending
fnf-20240331.xsd Edgar Link pending
fnf-20240331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fnf-20240331_cal.xml Edgar Link unprocessable
fnf-20240331_def.xml Edgar Link unprocessable
fnf-20240331_lab.xml Edgar Link unprocessable
fnf-20240331_pre.xml Edgar Link unprocessable
fnf-20240331_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending